Orthobiologics Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Orthobiologics Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Orthobiologics market.
This research report categorizes the global Orthobiologics market by top players/brands, region, type and end user. This report also studies the global Orthobiologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in your body.
The rising geriatric population can be considered as a beneficial prospect. Increasing geriatric population offers surplus opportunities for the manufactures of orthobiologics. The major root of amputations are diseases related to ageing as osteoarthritis, musculoskeletal diseases, spine deformity, etc. Increase incidence of accidents owing to increasing urbanization is also a major factor expected to create numerous opportunities for orthobiologics manufacturers. Elevating surgical procedures also presents growth opportunities for the market. The increased incidences of trauma cases, lifestyle related diseases and other chronic disorders have led to rise in number of orthopaedic surgeries at a global level. This growing trend is anticipated to increase the sales of orthobiologics products in present and forthcoming years.
The global Orthobiologics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The objectives of this study are to define, segment, and project the size of the Orthobiologics market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
- Medtronic
- NuVasive
- Stryker
- Zimmer
- Orthofix
- Anika Therapeutics
- DePuy Synthes (Johnson & Johnson)
- Bioventus
- Arthrex
- SeaSpine
- Sanofi-Aventis (Sanofi)
- Djo Global
- Seikagaku
- RTI Surgical
- Heraeus
- Fidia Pharma
- TRB
- Allosource
- Musculoskeletal Transplant Foundation
- Ito
Market size by Product
- Bone Growth Stimulators (BGS)
- Viscosupplements
- Bone Graft Substitute
Market size by End User
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedics Clinics
Market size by Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Malaysia
- Philippines
- Thailand
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Central & South America
- Brazil
- Rest of Central & South America
- Middle East & Africa
- GCC Countries
- Turkey
- Egypt
- South Africa
The study objectives of this report are:
- To study and analyze the global Orthobiologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
- To understand the structure of Orthobiologics market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Orthobiologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
- To project the value and sales volume of Orthobiologics submarkets, with respect to key regions.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.